Jo Varshney, PhD, DVM, discusses how artificial intelligence–powered simulations speed drug approvals and reduce clinical trial risk.
Jo Varshney, PhD, DVM
Advertisement
Jo Varshney, PhD, DVM, CEO and founder of VeriSIM Life.
Articles by Jo Varshney, PhD, DVM
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
Newly Unveiled ACA Premiums Show 26% Average Increase Before Subsidy Expiration
2
New PBM Laws Seek to Protect Independent Pharmacies but Could Raise Costs, Limit Patient Access
3
FDA Guidance to Remove One of the Largest Barriers to Biosimilar Development
4
Boosting RSV Vaccination in Older Adults Could Save Thousands
5
